Biomaterials for sequestration of growth factors and modulation of cell behavior

Growth factors (GFs) are proteins secreted by cells that regulate a variety of biological processes. Although they have long been proposed as potent therapeutic agents, their administration in a soluble form has proven costly and ineffective due to their short halfâ lives in biological environments....

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Advanced functional materials 2020-10, Vol.30 (44), p.n/a
Hauptverfasser: Teixeira, Simão P. B., Domingues, Rui Miguel Andrade, Shevchuk, Mariya, Gomes, Manuela E., Peppas, Nicholas A., Reis, R. L.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page n/a
container_issue 44
container_start_page
container_title Advanced functional materials
container_volume 30
creator Teixeira, Simão P. B.
Domingues, Rui Miguel Andrade
Shevchuk, Mariya
Gomes, Manuela E.
Peppas, Nicholas A.
Reis, R. L.
description Growth factors (GFs) are proteins secreted by cells that regulate a variety of biological processes. Although they have long been proposed as potent therapeutic agents, their administration in a soluble form has proven costly and ineffective due to their short halfâ lives in biological environments. Biomaterialâ based approaches are increasingly sought as alternatives to improve the efficacy or, ideally, replace the need for exogenous administration of GFs in regenerative medicine strategies. The means by which these systems evolve from biomaterials for conventional controlled release of GFs to the recent extracellular matrix (ECM)â inspired approaches for sequestering these labile molecules and regulating their spatiotemporal activity and presentation are reviewed. Focus is placed on biomaterials functionalized either with ECM components, which show promiscuous GF binding, or with targeted GF ligands (antibodies, aptamers, or peptides). The potential of synthetic platforms with abiotic affinity as costâ effective alternatives to the current biological ligands is also discussed. Overall, the various GF sequestering systems developed so far have remarkably improved the activity of GFs at reduced doses and, in some cases, completely avoided the need for their exogenous administration to guide cell fates. These bioinspired concepts thus enable the rational exploration of the full therapeutic potential of GFs in regenerative medicine. The authors acknowledge the financial support from project NORTE-01- 0145-FEDER-000021 supported by Norte Portugal Regional Operational Programme (NORTE 2020), under the PORTUGAL 2020 Partnership Agreement, through the European Regional Development Fund (ERDF); the European Union Framework Programme for Research and Innovation HORIZON 2020, under the TEAMING Grant Agreement No 739572 — The Discoveries CTR EU, Twinning Grant agreement No 810850 — Achilles, European Research Council Grant Agreement No 772817; FCT/MCTES (Fundação para a Ciência e a Tecnologia/ Ministério da Ciência, Tecnologia, e Ensino Superior), and the Fundo Social Europeu através do Programa Operacional do Capital Humano (FSE/POCH) in the framework of Ph.D. Grant PD/169/2013–PD/BD/143039/2018 for S.P.B.T., and project Grant PTDC/NAN-MAT/30595/2017.
doi_str_mv 10.1002/adfm.201909011
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_journals_2454584902</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2454584902</sourcerecordid><originalsourceid>FETCH-LOGICAL-c4191-6bac5db8d330fae56bf0438ec44a41c42841434d6b82f681917f69d19ffeeb9d3</originalsourceid><addsrcrecordid>eNqFkD1PwzAQhi0EEqWwMltiTvE5jmuP5aOAVAQDSGyW4w-aKqmLnbbqvyclqGJjuhue573Ti9AlkBEQQq-19c2IEpBEEoAjNAAOPMsJFceHHT5O0VlKC0JgPM7ZAL3eVKHRrYuVrhP2IeLkvtYutVG3VVji4PFnDNt2jr02bYgJ66XFTbDr-gAYV9e4dHO9qUI8Rye-i3IXv3OI3qf3b7eP2ezl4el2MssMAwkZL7UpbClsnhOvXcFLT1gunGFMMzCMCgYsZ5aXgnouOmXsubQgvXeulDYfoqs-dxXDz8NqEdZx2Z1UlBWsEEwS2lGjnjIxpBSdV6tYNTruFBC1b03tW1OH1jpB9sK2qt3uH1pN7qbPf13cu9FovVLRbarU6qRAUKo4K7p_vgHQGXwn</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2454584902</pqid></control><display><type>article</type><title>Biomaterials for sequestration of growth factors and modulation of cell behavior</title><source>Wiley Online Library Journals Frontfile Complete</source><creator>Teixeira, Simão P. B. ; Domingues, Rui Miguel Andrade ; Shevchuk, Mariya ; Gomes, Manuela E. ; Peppas, Nicholas A. ; Reis, R. L.</creator><creatorcontrib>Teixeira, Simão P. B. ; Domingues, Rui Miguel Andrade ; Shevchuk, Mariya ; Gomes, Manuela E. ; Peppas, Nicholas A. ; Reis, R. L.</creatorcontrib><description>Growth factors (GFs) are proteins secreted by cells that regulate a variety of biological processes. Although they have long been proposed as potent therapeutic agents, their administration in a soluble form has proven costly and ineffective due to their short halfâ lives in biological environments. Biomaterialâ based approaches are increasingly sought as alternatives to improve the efficacy or, ideally, replace the need for exogenous administration of GFs in regenerative medicine strategies. The means by which these systems evolve from biomaterials for conventional controlled release of GFs to the recent extracellular matrix (ECM)â inspired approaches for sequestering these labile molecules and regulating their spatiotemporal activity and presentation are reviewed. Focus is placed on biomaterials functionalized either with ECM components, which show promiscuous GF binding, or with targeted GF ligands (antibodies, aptamers, or peptides). The potential of synthetic platforms with abiotic affinity as costâ effective alternatives to the current biological ligands is also discussed. Overall, the various GF sequestering systems developed so far have remarkably improved the activity of GFs at reduced doses and, in some cases, completely avoided the need for their exogenous administration to guide cell fates. These bioinspired concepts thus enable the rational exploration of the full therapeutic potential of GFs in regenerative medicine. The authors acknowledge the financial support from project NORTE-01- 0145-FEDER-000021 supported by Norte Portugal Regional Operational Programme (NORTE 2020), under the PORTUGAL 2020 Partnership Agreement, through the European Regional Development Fund (ERDF); the European Union Framework Programme for Research and Innovation HORIZON 2020, under the TEAMING Grant Agreement No 739572 — The Discoveries CTR EU, Twinning Grant agreement No 810850 — Achilles, European Research Council Grant Agreement No 772817; FCT/MCTES (Fundação para a Ciência e a Tecnologia/ Ministério da Ciência, Tecnologia, e Ensino Superior), and the Fundo Social Europeu através do Programa Operacional do Capital Humano (FSE/POCH) in the framework of Ph.D. Grant PD/169/2013–PD/BD/143039/2018 for S.P.B.T., and project Grant PTDC/NAN-MAT/30595/2017.</description><identifier>ISSN: 1616-301X</identifier><identifier>EISSN: 1616-3028</identifier><identifier>DOI: 10.1002/adfm.201909011</identifier><language>eng</language><publisher>Hoboken: Wiley-VCH Verlag</publisher><subject>Affinity binding ; Antibodies ; Biological activity ; Biomaterials ; Biomedical materials ; Chemical compounds ; Controlled release ; Growth factors ; Ligands ; Materials science ; Molecular recognition ; Peptides ; Pharmacology ; Science &amp; Technology ; Sequestering ; Stem cells</subject><ispartof>Advanced functional materials, 2020-10, Vol.30 (44), p.n/a</ispartof><rights>2020 WILEY‐VCH Verlag GmbH &amp; Co. KGaA, Weinheim</rights><rights>2020 Wiley‐VCH GmbH</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c4191-6bac5db8d330fae56bf0438ec44a41c42841434d6b82f681917f69d19ffeeb9d3</citedby><cites>FETCH-LOGICAL-c4191-6bac5db8d330fae56bf0438ec44a41c42841434d6b82f681917f69d19ffeeb9d3</cites><orcidid>0000-0002-3654-9906 ; 0000-0002-2036-6291 ; 0000-0003-2764-4319</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1002%2Fadfm.201909011$$EPDF$$P50$$Gwiley$$H</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1002%2Fadfm.201909011$$EHTML$$P50$$Gwiley$$H</linktohtml><link.rule.ids>314,776,780,1411,27901,27902,45550,45551</link.rule.ids></links><search><creatorcontrib>Teixeira, Simão P. B.</creatorcontrib><creatorcontrib>Domingues, Rui Miguel Andrade</creatorcontrib><creatorcontrib>Shevchuk, Mariya</creatorcontrib><creatorcontrib>Gomes, Manuela E.</creatorcontrib><creatorcontrib>Peppas, Nicholas A.</creatorcontrib><creatorcontrib>Reis, R. L.</creatorcontrib><title>Biomaterials for sequestration of growth factors and modulation of cell behavior</title><title>Advanced functional materials</title><description>Growth factors (GFs) are proteins secreted by cells that regulate a variety of biological processes. Although they have long been proposed as potent therapeutic agents, their administration in a soluble form has proven costly and ineffective due to their short halfâ lives in biological environments. Biomaterialâ based approaches are increasingly sought as alternatives to improve the efficacy or, ideally, replace the need for exogenous administration of GFs in regenerative medicine strategies. The means by which these systems evolve from biomaterials for conventional controlled release of GFs to the recent extracellular matrix (ECM)â inspired approaches for sequestering these labile molecules and regulating their spatiotemporal activity and presentation are reviewed. Focus is placed on biomaterials functionalized either with ECM components, which show promiscuous GF binding, or with targeted GF ligands (antibodies, aptamers, or peptides). The potential of synthetic platforms with abiotic affinity as costâ effective alternatives to the current biological ligands is also discussed. Overall, the various GF sequestering systems developed so far have remarkably improved the activity of GFs at reduced doses and, in some cases, completely avoided the need for their exogenous administration to guide cell fates. These bioinspired concepts thus enable the rational exploration of the full therapeutic potential of GFs in regenerative medicine. The authors acknowledge the financial support from project NORTE-01- 0145-FEDER-000021 supported by Norte Portugal Regional Operational Programme (NORTE 2020), under the PORTUGAL 2020 Partnership Agreement, through the European Regional Development Fund (ERDF); the European Union Framework Programme for Research and Innovation HORIZON 2020, under the TEAMING Grant Agreement No 739572 — The Discoveries CTR EU, Twinning Grant agreement No 810850 — Achilles, European Research Council Grant Agreement No 772817; FCT/MCTES (Fundação para a Ciência e a Tecnologia/ Ministério da Ciência, Tecnologia, e Ensino Superior), and the Fundo Social Europeu através do Programa Operacional do Capital Humano (FSE/POCH) in the framework of Ph.D. Grant PD/169/2013–PD/BD/143039/2018 for S.P.B.T., and project Grant PTDC/NAN-MAT/30595/2017.</description><subject>Affinity binding</subject><subject>Antibodies</subject><subject>Biological activity</subject><subject>Biomaterials</subject><subject>Biomedical materials</subject><subject>Chemical compounds</subject><subject>Controlled release</subject><subject>Growth factors</subject><subject>Ligands</subject><subject>Materials science</subject><subject>Molecular recognition</subject><subject>Peptides</subject><subject>Pharmacology</subject><subject>Science &amp; Technology</subject><subject>Sequestering</subject><subject>Stem cells</subject><issn>1616-301X</issn><issn>1616-3028</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2020</creationdate><recordtype>article</recordtype><recordid>eNqFkD1PwzAQhi0EEqWwMltiTvE5jmuP5aOAVAQDSGyW4w-aKqmLnbbqvyclqGJjuhue573Ti9AlkBEQQq-19c2IEpBEEoAjNAAOPMsJFceHHT5O0VlKC0JgPM7ZAL3eVKHRrYuVrhP2IeLkvtYutVG3VVji4PFnDNt2jr02bYgJ66XFTbDr-gAYV9e4dHO9qUI8Rye-i3IXv3OI3qf3b7eP2ezl4el2MssMAwkZL7UpbClsnhOvXcFLT1gunGFMMzCMCgYsZ5aXgnouOmXsubQgvXeulDYfoqs-dxXDz8NqEdZx2Z1UlBWsEEwS2lGjnjIxpBSdV6tYNTruFBC1b03tW1OH1jpB9sK2qt3uH1pN7qbPf13cu9FovVLRbarU6qRAUKo4K7p_vgHQGXwn</recordid><startdate>20201001</startdate><enddate>20201001</enddate><creator>Teixeira, Simão P. B.</creator><creator>Domingues, Rui Miguel Andrade</creator><creator>Shevchuk, Mariya</creator><creator>Gomes, Manuela E.</creator><creator>Peppas, Nicholas A.</creator><creator>Reis, R. L.</creator><general>Wiley-VCH Verlag</general><general>Wiley Subscription Services, Inc</general><scope>RCLKO</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7SP</scope><scope>7SR</scope><scope>7U5</scope><scope>8BQ</scope><scope>8FD</scope><scope>JG9</scope><scope>L7M</scope><orcidid>https://orcid.org/0000-0002-3654-9906</orcidid><orcidid>https://orcid.org/0000-0002-2036-6291</orcidid><orcidid>https://orcid.org/0000-0003-2764-4319</orcidid></search><sort><creationdate>20201001</creationdate><title>Biomaterials for sequestration of growth factors and modulation of cell behavior</title><author>Teixeira, Simão P. B. ; Domingues, Rui Miguel Andrade ; Shevchuk, Mariya ; Gomes, Manuela E. ; Peppas, Nicholas A. ; Reis, R. L.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c4191-6bac5db8d330fae56bf0438ec44a41c42841434d6b82f681917f69d19ffeeb9d3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2020</creationdate><topic>Affinity binding</topic><topic>Antibodies</topic><topic>Biological activity</topic><topic>Biomaterials</topic><topic>Biomedical materials</topic><topic>Chemical compounds</topic><topic>Controlled release</topic><topic>Growth factors</topic><topic>Ligands</topic><topic>Materials science</topic><topic>Molecular recognition</topic><topic>Peptides</topic><topic>Pharmacology</topic><topic>Science &amp; Technology</topic><topic>Sequestering</topic><topic>Stem cells</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Teixeira, Simão P. B.</creatorcontrib><creatorcontrib>Domingues, Rui Miguel Andrade</creatorcontrib><creatorcontrib>Shevchuk, Mariya</creatorcontrib><creatorcontrib>Gomes, Manuela E.</creatorcontrib><creatorcontrib>Peppas, Nicholas A.</creatorcontrib><creatorcontrib>Reis, R. L.</creatorcontrib><collection>RCAAP open access repository</collection><collection>CrossRef</collection><collection>Electronics &amp; Communications Abstracts</collection><collection>Engineered Materials Abstracts</collection><collection>Solid State and Superconductivity Abstracts</collection><collection>METADEX</collection><collection>Technology Research Database</collection><collection>Materials Research Database</collection><collection>Advanced Technologies Database with Aerospace</collection><jtitle>Advanced functional materials</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Teixeira, Simão P. B.</au><au>Domingues, Rui Miguel Andrade</au><au>Shevchuk, Mariya</au><au>Gomes, Manuela E.</au><au>Peppas, Nicholas A.</au><au>Reis, R. L.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Biomaterials for sequestration of growth factors and modulation of cell behavior</atitle><jtitle>Advanced functional materials</jtitle><date>2020-10-01</date><risdate>2020</risdate><volume>30</volume><issue>44</issue><epage>n/a</epage><issn>1616-301X</issn><eissn>1616-3028</eissn><abstract>Growth factors (GFs) are proteins secreted by cells that regulate a variety of biological processes. Although they have long been proposed as potent therapeutic agents, their administration in a soluble form has proven costly and ineffective due to their short halfâ lives in biological environments. Biomaterialâ based approaches are increasingly sought as alternatives to improve the efficacy or, ideally, replace the need for exogenous administration of GFs in regenerative medicine strategies. The means by which these systems evolve from biomaterials for conventional controlled release of GFs to the recent extracellular matrix (ECM)â inspired approaches for sequestering these labile molecules and regulating their spatiotemporal activity and presentation are reviewed. Focus is placed on biomaterials functionalized either with ECM components, which show promiscuous GF binding, or with targeted GF ligands (antibodies, aptamers, or peptides). The potential of synthetic platforms with abiotic affinity as costâ effective alternatives to the current biological ligands is also discussed. Overall, the various GF sequestering systems developed so far have remarkably improved the activity of GFs at reduced doses and, in some cases, completely avoided the need for their exogenous administration to guide cell fates. These bioinspired concepts thus enable the rational exploration of the full therapeutic potential of GFs in regenerative medicine. The authors acknowledge the financial support from project NORTE-01- 0145-FEDER-000021 supported by Norte Portugal Regional Operational Programme (NORTE 2020), under the PORTUGAL 2020 Partnership Agreement, through the European Regional Development Fund (ERDF); the European Union Framework Programme for Research and Innovation HORIZON 2020, under the TEAMING Grant Agreement No 739572 — The Discoveries CTR EU, Twinning Grant agreement No 810850 — Achilles, European Research Council Grant Agreement No 772817; FCT/MCTES (Fundação para a Ciência e a Tecnologia/ Ministério da Ciência, Tecnologia, e Ensino Superior), and the Fundo Social Europeu através do Programa Operacional do Capital Humano (FSE/POCH) in the framework of Ph.D. Grant PD/169/2013–PD/BD/143039/2018 for S.P.B.T., and project Grant PTDC/NAN-MAT/30595/2017.</abstract><cop>Hoboken</cop><pub>Wiley-VCH Verlag</pub><doi>10.1002/adfm.201909011</doi><tpages>26</tpages><orcidid>https://orcid.org/0000-0002-3654-9906</orcidid><orcidid>https://orcid.org/0000-0002-2036-6291</orcidid><orcidid>https://orcid.org/0000-0003-2764-4319</orcidid><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1616-301X
ispartof Advanced functional materials, 2020-10, Vol.30 (44), p.n/a
issn 1616-301X
1616-3028
language eng
recordid cdi_proquest_journals_2454584902
source Wiley Online Library Journals Frontfile Complete
subjects Affinity binding
Antibodies
Biological activity
Biomaterials
Biomedical materials
Chemical compounds
Controlled release
Growth factors
Ligands
Materials science
Molecular recognition
Peptides
Pharmacology
Science & Technology
Sequestering
Stem cells
title Biomaterials for sequestration of growth factors and modulation of cell behavior
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-08T11%3A49%3A07IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Biomaterials%20for%20sequestration%20of%20growth%20factors%20and%20modulation%20of%20cell%20behavior&rft.jtitle=Advanced%20functional%20materials&rft.au=Teixeira,%20Sim%C3%A3o%20P.%20B.&rft.date=2020-10-01&rft.volume=30&rft.issue=44&rft.epage=n/a&rft.issn=1616-301X&rft.eissn=1616-3028&rft_id=info:doi/10.1002/adfm.201909011&rft_dat=%3Cproquest_cross%3E2454584902%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2454584902&rft_id=info:pmid/&rfr_iscdi=true